User Fees Could Chafe Cosmetics In OTC Monograph Reform Proposal
This article was originally published in The Rose Sheet
Executive Summary
Products marketed for cosmetic use but formulated with drugs are regulated as topical drugs and would be subject to potential OTC user fees, although the products have little similarity with oral or nasal delivery nonprescription drugs also available under FDA's monograph system, consultant David Steinberg says.